Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-20

FDA Approved: TASIMELTEON — Original Application (Apotex Corp.)

View source ↗

Summary

The FDA approved Apotex Corp.'s original ANDA for tasimelteon, establishing a generic version of the sleep-wake disorder medication. Tasimelteon is used for Non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tasimelteon (tasimelteon)

Snippet

ORIG AP for TASIMELTEON (TASIMELTEON)